Skip to main content

Table 1 Demographic and clinical characteristics of patients

From: [99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression

Patient

Age

Gender

BMI (kg/m2)

Clinical staging

Tumour PD-L1 expression (%)

ECOG performance status

Smoking status

Cardiovascular risk factors

1

63

M

32.3

TX N2 M1a

 < 1

1

Ex smoker

Hypertension, obesity

2

59

M

20.8

T4 N3 M0

70

1

Ex smoker

3

53

F

27.4

T4 N3 M1c

55

0

Ex smoker

4

66

F

23.4

T1b N0 M1b

 < 1

0

Ex smoker

5

58

F

23.4

T3 NX M1b

90

1

Ex smoker

6

64

M

29.8

T4 N3 M1a

80

1

Ex smoker

Peripheral vascular disease

7

73

M

33.3

T4 N2 M1

55

1

Ex smoker

Chronic kidney disease, obesity

8

72

M

24.9

T1b N2 M1b

95

1

Ex smoker

Hypertension

9

75

F

32.6

T2a N2 M1b

 < 1

1

Ex smoker

Cerebrovascular disease, obesity

10

59

M

24.2

T2a N2 M1a

 < 1

0

Smoker

Diabetes mellitus

  1. PD-L1 expression measured using SP263 assay